-
Je něco špatně v tomto záznamu ?
RE: frameshift variant FANCL*c.1096_1099dupATTA is not associated with high breast cancer risk
P. Zemankova, F. Lhota, P. Kleiblova, J. Soukupova, M. Vocka, M. Janatova, Z. Kleibl,
Clinical genetics.
2016 ;
90 (4) :
387-9.
Jazyk angličtina Země Dánsko
Typ dokumentu dopisy, práce podpořená grantem, komentáře
Perzistentní odkaz
https://www.medvik.cz/link/bmc18034081
Grantová podpora
NV15-27695A
MZ0
CEP - Centrální evidence projektů
PubMed
27659787
DOI
10.1111/cge.12842
Knihovny.cz E-zdroje
- MeSH
- Fanconiho anemie * MeSH
- lidé MeSH
- nádory prsu MeSH
- posunová mutace MeSH
- protein FANCL genetika MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- dopisy MeSH
- komentáře MeSH
- práce podpořená grantem MeSH
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18034081
- 003
- CZ-PrNML
- 005
- 20220124124954.0
- 007
- ta
- 008
- 181008s2016 dk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/cge.12842 $2 doi
- 035 __
- $a (PubMed)27659787
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a dk
- 100 1_
- $a Zemánková, Petra $u Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic. $7 xx0239540
- 245 10
- $a RE: frameshift variant FANCL*c.1096_1099dupATTA is not associated with high breast cancer risk / $c P. Zemankova, F. Lhota, P. Kleiblova, J. Soukupova, M. Vocka, M. Janatova, Z. Kleibl,
- 650 _2
- $a nádory prsu $7 D001943
- 650 12
- $a Fanconiho anemie $7 D005199
- 650 _2
- $a protein FANCL $x genetika $7 D052240
- 650 _2
- $a posunová mutace $7 D016368
- 650 _2
- $a lidé $7 D006801
- 655 _2
- $a dopisy $7 D016422
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a komentáře $7 D016420
- 700 1_
- $a Lhota, F $u Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic. Centre for Medical Genetics and Reproductive Medicine GENNET, Prague, Czech Republic.
- 700 1_
- $a Kleiblova, P $u Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic. Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic.
- 700 1_
- $a Soukupova, J $u Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
- 700 1_
- $a Vocka, M $u Department of Oncology, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic.
- 700 1_
- $a Janatova, M $u Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
- 700 1_
- $a Kleibl, Z $u Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic. zdekleje@lf1.cuni.cz.
- 773 0_
- $w MED00001127 $t Clinical genetics $x 1399-0004 $g Roč. 90, č. 4 (2016), s. 387-9
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27659787 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20181008 $b ABA008
- 991 __
- $a 20220124124953 $b ABA008
- 999 __
- $a ok $b bmc $g 1341029 $s 1031075
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 90 $c 4 $d 387-9 $i 1399-0004 $m Clinical genetics $n Clin Genet $x MED00001127
- GRA __
- $a NV15-27695A $p MZ0
- LZP __
- $a Pubmed-20181008
